Skip to content

Released Mar 4, 2013, after the close

10-K filed Mar 4, 2013, 63 days after period end · 0001144204-13-012708

Q4 2012 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$368.00Kderived−24.7% vs Q4 2011−39.1% vs Q3 2012
Net Income-$4.46MderivedN/M vs Q4 2011N/M vs Q3 2012
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$79,000−49.7%
Operating Incomederived-$1,112,000N/M
Operating Cash Flowderived-$458,000N/M
Free Cash Flowderived-$459,000—
Margins · derived
Gross margin21.5%−10.6 pt vs Q4 2011
Operating margin-302.2%−171.1 pt vs Q4 2011
Net margin-1211.7%−132.7 pt vs Q4 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2012derived from reported figuresQ4 2011derived from reported figuresQ4 2010derived from reported figures
Revenue$368.00K$489.00K—
Net Income-$4.46M-$5.28M—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR